Open any health news feed today and you’ll see a familiar headline:
Scientists develop new drug for X or New jab could prevent Y.
It happens so often that we’ve stopped noticing the pattern but the pattern is the story.
Somewhere along the way, medicine narrowed. Where a good clinician once asked why a body was struggling, what was out of balance, what habit, exposure or deficiency was driving the symptom, the default answer has increasingly become: suppress it, block it, inject against it.
One lever, pulled again and again, for problems that are rarely one-dimensional themselves.
So let’s call it what it is: it’s one-dimensional healthcare.
A single axis of intervention, pharmacological, applied to conditions that usually have multiple, tangled causes. Diet, movement, sleep, stress, environment, gut health, chronic low-grade inflammation.
Our previous piece on Metabolic Dysfunction explores precisely this.
Many conditions respond to patience and lifestyle changes but patience doesn’t fit neatly into a fifteen-minute appointment and it doesn’t produce a headline.
None of this is an argument against medicine.
The concern isn’t the existence of pharmaceutical tools per se but the narrowing of medicine down to those tools alone. Root-cause investigation used to be step one, not a fallback option for people who didn’t respond to treatment.
It’s fair to ask why this narrowing happened.
Incentives matter.
A drug that’s taken daily for decades is commercially a very different proposition to a dietary change that resolves a problem in six months.
Research funding, guideline committees, and continuing education all flow disproportionately through channels shaped by companies with a product to sell.
That’s not a conspiracy theory, it’s a description of how funding structures shape which questions get asked and which get quietly forgotten.
Whether that’s a deliberate strategy or simply the predictable outcome of a system optimised for revenue rather than resolution is a harder question to answer but reasonable people land in different places on it.
However, the effect is the same either way: patients are handed a prescription before they’re handed a proper investigation.
The fix isn’t to reject modern medicine. It’s to insist it goes back to being multi-dimensional, in other words, viewing the drug or the injection as one tool among many, not the whole toolbox.
Ask why before what pill.
Our bodies have an amazing capacity to self-heal if given the correct environment so let’s give that a fair hearing before reaching for something that only manages the symptom.
That’s a harder sell than a headline.
It’s also, I’d argue, the only kind of medicine worth having.
No posts
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.